{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:52:39Z","timestamp":1791381159744,"version":"4.3.3"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hunan Medical Scientific Research Project","award":["W20243020"],"award-info":[{"award-number":["W20243020"]}]},{"name":"Chinese Cardiovascular Association-ASCVD Fund,","award":["2023-CCA-ASCVD-018"],"award-info":[{"award-number":["2023-CCA-ASCVD-018"]}]},{"name":"Project of State Key Clinical Department","award":["Z2023058"],"award-info":[{"award-number":["Z2023058"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-026-03014-0","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T08:14:49Z","timestamp":1783757689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipoprotein(a) and atherosclerosis risk across estimated glucose disposal rate strata: evaluating synergistic predictive utility"],"prefix":"10.1186","volume":"25","author":[{"given":"Yihui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"3014_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1963.tb01808.x","author":"K Berg","year":"1963","unstructured":"Berg K. A new serum type, system in man\u2013the LP system. Acta Pathol Microbiol Scand. 1963;59:369-82. https:\/\/doi.org\/10.1111\/j.1699-0463.1963.tb01808.x.\u00a0","journal-title":"Acta Pathol Microbiol Scand"},{"issue":"11","key":"3014_CR2","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1161\/atvbaha.116.308011","volume":"36","author":"S Varvel","year":"2016","unstructured":"Varvel S, McConnell JP, Tsimikas S. Prevalence of Elevated Lp(a) Mass Levels and Patient Thresholds in 532 359 Patients in the United States. Arterioscler Thromb Vasc Biol. 2016;36(11):2239\u201345. https:\/\/doi.org\/10.1161\/atvbaha.116.308011.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"3014_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.7555\/jbr.31.20160009","volume":"31","author":"AD Tselepis","year":"2018","unstructured":"Tselepis AD. Oxidized phospholipids and lipoprotein-associated phospholipase A(2) as important determinants of Lp(a) functionality and pathophysiological role. J Biomed Res. 2018;31(1):13\u201322. https:\/\/doi.org\/10.7555\/jbr.31.20160009.","journal-title":"J Biomed Res"},{"key":"3014_CR4","doi-asserted-by":"publisher","unstructured":"Krittanawong C, Maitra NS, El-Sherbini AH, Shah N, Lavie CJ, Shapiro MD, et al. Lipoprotein(a) in clinical practice: A guide for the clinician. Prog Cardiovasc Dis. 2023;7928\u201336. https:\/\/doi.org\/10.1016\/j.pcad.2023.07.006.","DOI":"10.1016\/j.pcad.2023.07.006"},{"issue":"16","key":"3014_CR5","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.jacc.2024.02.031","volume":"83","author":"ND Wong","year":"2024","unstructured":"Wong ND, Fan W, Hu X, Ballantyne C, Hoodgeveen RC, Tsai MY, et al. Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled Prospective Cohort. J Am Coll Cardiol. 2024;83(16):1511\u201325. https:\/\/doi.org\/10.1016\/j.jacc.2024.02.031.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3014_CR6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1161\/atvbaha.120.315291","volume":"41","author":"AP Patel","year":"2021","unstructured":"Patel AP, Wang M, Pirruccello JP, Ellinor PT, Ng K, Kathiresan S, et al. Lp(a) (Lipoprotein[a]) Concentrations and incident atherosclerotic cardiovascular disease: new insights from a large National Biobank. Arterioscler Thromb Vasc Biol. 2021;41(1):465\u201374. https:\/\/doi.org\/10.1161\/atvbaha.120.315291.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"3014_CR7","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.jacc.2023.12.031","volume":"83","author":"AN Berman","year":"2024","unstructured":"Berman AN, Biery DW, Besser SA, Singh A, Shiyovich A, Weber BN, et al. Lipoprotein(a) and major adverse cardiovascular events in patients with or without baseline atherosclerotic cardiovascular disease. J Am Coll Cardiol. 2024;83(9):873\u201386. https:\/\/doi.org\/10.1016\/j.jacc.2023.12.031.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"3014_CR8","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1001\/jamacardio.2018.1470","volume":"3","author":"S Burgess","year":"2018","unstructured":"Burgess S, Ference BA, Staley JR, Freitag DF, Mason AM, Nielsen SF, et al. Association of LPA variants with risk of coronary disease and the implications for Lipoprotein(a)-lowering therapies: a mendelian randomization analysis. JAMA Cardiol. 2018;3(7):619\u201327. https:\/\/doi.org\/10.1001\/jamacardio.2018.1470.","journal-title":"JAMA Cardiol"},{"issue":"1","key":"3014_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12933-025-02991-3","volume":"25","author":"X Zou","year":"2025","unstructured":"Zou X, Zhang F, He C, Zhang W, Tang R, Zhu J, et al. Additive value of combining triglyceride-glucose index and estimated glucose disposal rate for incident stroke prediction across glycaemic-regulation subgroups: a prospective cohort of 5,789 Chinese adults. Cardiovasc Diabetol. 2025;25(1):21. https:\/\/doi.org\/10.1186\/s12933-025-02991-3.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3014_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12933-023-01925-1","volume":"22","author":"Z Lu","year":"2023","unstructured":"Lu Z, Xiong Y, Feng X, Yang K, Gu H, Zhao X, et al. Insulin resistance estimated by estimated glucose disposal rate predicts outcomes in acute ischemic stroke patients. Cardiovasc Diabetol. 2023;22(1):225. https:\/\/doi.org\/10.1186\/s12933-023-01925-1.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3014_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12933-024-02396-8","volume":"23","author":"HM He","year":"2024","unstructured":"He HM, Xie YY, Chen Q, Li YK, Li XX, Mu YK, et al. The additive effect of the triglyceride-glucose index and estimated glucose disposal rate on long-term mortality among individuals with and without diabetes: a population-based study. Cardiovasc Diabetol. 2024;23(1):307. https:\/\/doi.org\/10.1186\/s12933-024-02396-8.","journal-title":"Cardiovasc Diabetol"},{"key":"3014_CR12","doi-asserted-by":"publisher","unstructured":"Wang Z, Zhou Q, Zheng T, Huang T, Yi K. Association between estimated glucose disposal rate and the risk of atherosclerotic cardiovascular disease: insight from cross-sectional and retrospective cohort studies. Front Nutr. 2025;121664591. https:\/\/doi.org\/10.3389\/fnut.2025.1664591.","DOI":"10.3389\/fnut.2025.1664591"},{"issue":"1","key":"3014_CR13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s12933-024-02437-2","volume":"23","author":"J Yi","year":"2024","unstructured":"Yi J, Qu C, Li X, Gao H. Insulin resistance assessed by estimated glucose disposal rate and risk of atherosclerotic cardiovascular diseases incidence: the multi-ethnic study of atherosclerosis. Cardiovasc Diabetol. 2024;23(1):349. https:\/\/doi.org\/10.1186\/s12933-024-02437-2.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"3014_CR14","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1194\/jlr.P049015","volume":"56","author":"L Ding","year":"2015","unstructured":"Ding L, Song A, Dai M, Xu M, Sun W, Xu B, et al. Serum lipoprotein (a) concentrations are inversely associated with T2D, prediabetes, and insulin resistance in a middle-aged and elderly Chinese population. J Lipid Res. 2015;56(4):920\u20136. https:\/\/doi.org\/10.1194\/jlr.P049015.","journal-title":"J Lipid Res"},{"key":"3014_CR15","doi-asserted-by":"publisher","unstructured":"Wang H, Fan JL. Association between lipoprotein(a) and insulin resistance in Chinese adults: results from the China health and nutrition survey. Front Endocrinol (Lausanne). 2023;141234140. https:\/\/doi.org\/10.3389\/fendo.2023.1234140.","DOI":"10.3389\/fendo.2023.1234140"},{"issue":"1","key":"3014_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12933-017-0520-z","volume":"16","author":"E Paige","year":"2017","unstructured":"Paige E, Masconi KL, Tsimikas S, Kronenberg F, Santer P, Weger S, et al. Lipoprotein(a) and incident type-2 diabetes: results from the prospective Bruneck study and a meta-analysis of published literature. Cardiovasc Diabetol. 2017;16(1):38. https:\/\/doi.org\/10.1186\/s12933-017-0520-z.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"3014_CR17","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.metabol.2014.08.007","volume":"63","author":"L Marzano","year":"2014","unstructured":"Marzano L, Colussi G, Del Torre M, Sechi LA, Catena C. Relationships of plasma lipoprotein(a) levels with insulin resistance in hypertensive patients. Metabolism. 2014;63(11):1439\u201346. https:\/\/doi.org\/10.1016\/j.metabol.2014.08.007.","journal-title":"Metabolism"},{"key":"3014_CR18","doi-asserted-by":"publisher","unstructured":"Todoric J, Handisurya A, Leitner K, Harreiter J, Hoermann G, Kautzky-Willer A. Lipoprotein(a) is not related to markers of insulin resistance in pregnancy. Cardiovasc Diabetol. 2013;12138. https:\/\/doi.org\/10.1186\/1475-2840-12-138.","DOI":"10.1186\/1475-2840-12-138"},{"issue":"1","key":"3014_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12933-025-02591-1","volume":"24","author":"C Li","year":"2025","unstructured":"Li C, Zhang Z, Luo X, Xiao Y, Tu T, Liu C, et al. The triglyceride-glucose index and its obesity-related derivatives as predictors of all-cause and cardiovascular mortality in hypertensive patients: insights from NHANES data with machine learning analysis. Cardiovasc Diabetol. 2025;24(1):47. https:\/\/doi.org\/10.1186\/s12933-025-02591-1.","journal-title":"Cardiovasc Diabetol"},{"key":"3014_CR20","doi-asserted-by":"publisher","unstructured":"Wang Y, Liu L, Yang P, Li Y, Zhou Y, Yang S, et al. Associations of triglyceride-glucose index cumulative exposure and variability with the transitions from normoglycaemia to prediabetes and prediabetes to diabetes: Insights from a cohort study. Diabetes Res Clin Pract. 2024;217111867. https:\/\/doi.org\/10.1016\/j.diabres.2024.111867.","DOI":"10.1016\/j.diabres.2024.111867"},{"issue":"5 Pt 1","key":"3014_CR21","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1161\/01.cir.88.5.2460","volume":"88","author":"D Perloff","year":"1993","unstructured":"Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M, et al. Human blood pressure determination by sphygmomanometry. Circulation. 1993;88(5 Pt 1):2460\u201370. https:\/\/doi.org\/10.1161\/01.cir.88.5.2460.","journal-title":"Circulation"},{"issue":"1","key":"3014_CR22","doi-asserted-by":"publisher","first-page":"e13736","DOI":"10.1002\/jcsm.13736","volume":"16","author":"W Liu","year":"2025","unstructured":"Liu W, Wang X, Guo Y, Gao Y, Song H, Yao Y, et al. Sarcopenia and Insulin resistance collective effect on atrial fibrillation risk: a non-diabetic elderly cohort study. J Cachexia Sarcopenia Muscle. 2025;16(1):e13736. https:\/\/doi.org\/10.1002\/jcsm.13736.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"3014_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12937-021-00710-8","volume":"20","author":"S Peng","year":"2021","unstructured":"Peng S, Wang J, Xiao Y, Yin L, Peng Y, Yang L, et al. The association of carotid artery atherosclerosis with the estimated excretion levels of urinary sodium and potassium and their ratio in Chinese adults. Nutr J. 2021;20(1):50. https:\/\/doi.org\/10.1186\/s12937-021-00710-8.","journal-title":"Nutr J"},{"issue":"10459","key":"3014_CR24","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/s0140-6736(24)01308-4","volume":"404","author":"BG Nordestgaard","year":"2024","unstructured":"Nordestgaard BG Langsted. Lipoprotein(a) and cardiovascular disease. Lancet. 2024;404(10459):1255\u201364. https:\/\/doi.org\/10.1016\/s0140-6736(24)01308-4.","journal-title":"Lancet"},{"issue":"1","key":"3014_CR25","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1161\/atv.0000000000000147","volume":"42","author":"G Reyes-Soffer","year":"2022","unstructured":"Reyes-Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR, et al. Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol. 2022;42(1):e48\u201360. https:\/\/doi.org\/10.1161\/atv.0000000000000147.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"3014_CR26","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12933-021-01268-9","volume":"20","author":"X Ding","year":"2021","unstructured":"Ding X, Wang X, Wu J, Zhang M, Cui M. Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20(1):76. https:\/\/doi.org\/10.1186\/s12933-021-01268-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3014_CR27","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s12933-023-02090-1","volume":"22","author":"J Iglesies-Grau","year":"2023","unstructured":"Iglesies-Grau J, Garcia-Alvarez A, Oliva B, Mendieta G, Garc\u00eda-Lunar I, Fuster JJ, et al. Early insulin resistance in normoglycemic low-risk individuals is associated with subclinical atherosclerosis. Cardiovasc Diabetol. 2023;22(1):350. https:\/\/doi.org\/10.1186\/s12933-023-02090-1.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"3014_CR28","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1161\/atvbaha.112.251306","volume":"32","author":"JD Spence","year":"2012","unstructured":"Spence JD, Koschinsky M. Mechanisms of lipoprotein(a) pathogenicity: prothrombotic, proatherosclerotic, or both? Arterioscler Thromb Vasc Biol. 2012;32(7):1550\u20131. https:\/\/doi.org\/10.1161\/atvbaha.112.251306.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"3014_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2174\/1570161117666181129113611","volume":"17","author":"A Baranowska-Bik","year":"2019","unstructured":"Baranowska-Bik A, Bik W. Vascular dysfunction and insulin resistance in aging. Curr Vasc Pharmacol. 2019;17(5):465\u201375. https:\/\/doi.org\/10.2174\/1570161117666181129113611.","journal-title":"Curr Vasc Pharmacol"},{"key":"3014_CR30","doi-asserted-by":"publisher","unstructured":"Cai X, Sun J, Jin A, Jing J, Wang S, Mei L, et al. Association of insulin resistance with intra- and extra-cranial atherosclerotic burden in the nondiabetic community population. Neurobiol Dis. 2023;186106268. https:\/\/doi.org\/10.1016\/j.nbd.2023.106268.","DOI":"10.1016\/j.nbd.2023.106268"},{"issue":"1","key":"3014_CR31","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12933-024-02485-8","volume":"23","author":"X Zheng","year":"2024","unstructured":"Zheng X, Han W, Li Y, Jiang M, Ren X, Yang P, et al. Changes in the estimated glucose disposal rate and incident cardiovascular disease: two large prospective cohorts in Europe and Asia. Cardiovasc Diabetol. 2024;23(1):403. https:\/\/doi.org\/10.1186\/s12933-024-02485-8.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3014_CR32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12933-025-02729-1","volume":"24","author":"B Dong","year":"2025","unstructured":"Dong B, Chen Y, Yang X, Chen Z, Zhang H, Gao Y, et al. Estimated glucose disposal rate outperforms other insulin resistance surrogates in predicting incident cardiovascular diseases in cardiovascular-kidney-metabolic syndrome stages 0\u20133 and the development of a machine learning prediction model: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):163. https:\/\/doi.org\/10.1186\/s12933-025-02729-1.","journal-title":"Cardiovasc Diabetol"},{"issue":"Suppl 1","key":"3014_CR33","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.33549\/physiolres.933583","volume":"66","author":"H Vaverkov\u00e1","year":"2017","unstructured":"Vaverkov\u00e1 H, Kar\u00e1sek D, Halenka M, Cib\u00ed\u010dkov\u00e1 L, Kub\u00ed\u010dkov\u00e1 V. Inverse association of lipoprotein (a) with markers of insulin resistance in dyslipidemic subjects. Physiol Res. 2017;66(Suppl 1):S113\u201320. https:\/\/doi.org\/10.33549\/physiolres.933583.","journal-title":"Physiol Res"},{"key":"3014_CR34","doi-asserted-by":"publisher","unstructured":"Liu Y, Zou J, Li X, Zhao X, Zou J, Liu S, et al. Effect of the interaction between obstructive sleep apnea and Lipoprotein(a) on insulin resistance: a large-scale cross-sectional study. J Diabetes Res. 2019;20199583286. https:\/\/doi.org\/10.1155\/2019\/9583286.","DOI":"10.1155\/2019\/9583286"},{"issue":"39","key":"3014_CR35","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","volume":"43","author":"F Kronenberg","year":"2022","unstructured":"Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43(39):3925\u201346. https:\/\/doi.org\/10.1093\/eurheartj\/ehac361.","journal-title":"Eur Heart J"},{"issue":"8","key":"3014_CR36","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1161\/01.atv.18.8.1335","volume":"18","author":"DL Rainwater","year":"1998","unstructured":"Rainwater DL, Haffner SM. Insulin and 2-hour glucose levels are inversely related to Lp(a) concentrations controlled for LPA genotype. Arterioscler Thromb Vasc Biol. 1998;18(8):1335\u201341. https:\/\/doi.org\/10.1161\/01.atv.18.8.1335.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"3014_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s001250051110","volume":"42","author":"DM Neele","year":"1999","unstructured":"Neele DM, de Wit EC, Princen HM. Insulin suppresses apolipoprotein(a) synthesis by primary cultures of cynomolgus monkey hepatocytes. Diabetologia. 1999;42(1):41\u20134. https:\/\/doi.org\/10.1007\/s001250051110.","journal-title":"Diabetologia"},{"issue":"4","key":"3014_CR38","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2174\/138161282004140213145551","volume":"20","author":"A Onat","year":"2014","unstructured":"Onat A, Can G. Enhanced proinflammatory state and autoimmune activation: a breakthrough to understanding chronic diseases. Curr Pharm Des. 2014;20(4):575\u201384. https:\/\/doi.org\/10.2174\/138161282004140213145551.","journal-title":"Curr Pharm Des"},{"issue":"4","key":"3014_CR39","doi-asserted-by":"publisher","first-page":"e042361","DOI":"10.1161\/jaha.125.042361","volume":"15","author":"R Kazibwe","year":"2026","unstructured":"Kazibwe R, Schaich CL, Chevli PA, Kingsley JA, Mirzai S, Namutebi JH, et al. Lipoprotein(a), Insulin Resistance, and Cardiovascular Disease in the UK Biobank. J Am Heart Assoc. 2026;15(4):e042361. https:\/\/doi.org\/10.1161\/jaha.125.042361.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"3014_CR40","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2337\/dc24-2110","volume":"48","author":"GG Schwartz","year":"2025","unstructured":"Schwartz GG, Szarek M, Jukema JW, Cobbaert CM, Reijnders E, Bittner VA, et al. Risk of Incident Diabetes Related to Lipoprotein(a), LDL Cholesterol, and Their Changes With Alirocumab: Post Hoc Analyses of the ODYSSEY OUTCOMES Randomized Trial. Diabetes Care. 2025;48(4):596\u2013604. https:\/\/doi.org\/10.2337\/dc24-2110.","journal-title":"Diabetes Care"},{"issue":"2","key":"3014_CR41","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1001\/jamacardio.2025.5043","volume":"11","author":"AT Nordestgaard","year":"2026","unstructured":"Nordestgaard AT, Chasman DI, Moorthy V, Kraaijenhof JM, Cook NR, Lee IM, et al. Thirty-Year Risk of Cardiovascular Disease Among Healthy Women According to Clinical Thresholds of Lipoprotein(a). JAMA Cardiol. 2026;11(2):175\u201385. https:\/\/doi.org\/10.1001\/jamacardio.2025.5043.","journal-title":"JAMA Cardiol"},{"issue":"10155","key":"3014_CR42","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/s0140-6736(18)31652-0","volume":"392","author":"P Willeit","year":"2018","unstructured":"Willeit P, Ridker PM, Nestel PJ, Simes J, Tonkin AM, Pedersen TR, et al. Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials. Lancet. 2018;392(10155):1311\u201320. https:\/\/doi.org\/10.1016\/s0140-6736(18)31652-0.","journal-title":"Lancet"},{"issue":"4","key":"3014_CR43","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/mol.0000000000000996","volume":"36","author":"P Corral","year":"2025","unstructured":"Corral P, Matta MG, Schreier L. Are Lipoprotein(a) levels decreased in insulin resistance and type 2 diabetes? Curr Opin Lipidol. 2025;36(4):179\u201384. https:\/\/doi.org\/10.1097\/mol.0000000000000996.","journal-title":"Curr Opin Lipidol"},{"issue":"16","key":"3014_CR44","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.jacc.2023.02.033","volume":"81","author":"WA Malick","year":"2023","unstructured":"Malick WA, Goonewardena SN, Koenig W, Rosenson RS. Clinical Trial Design for Lipoprotein(a)-Lowering Therapies: JACC Focus Seminar 2\/3. J Am Coll Cardiol. 2023;81(16):1633\u201345. https:\/\/doi.org\/10.1016\/j.jacc.2023.02.033.","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"3014_CR45","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1093\/eurheartj\/ehz310","volume":"41","author":"S Tsimikas","year":"2020","unstructured":"Tsimikas S, Gordts P, Nora C, Yeang C, Witztum JL. Statin therapy increases lipoprotein(a) levels. Eur Heart J. 2020;41(24):2275\u201384. https:\/\/doi.org\/10.1093\/eurheartj\/ehz310.","journal-title":"Eur Heart J"},{"issue":"1","key":"3014_CR46","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12933-024-02538-y","volume":"23","author":"Y Chen","year":"2024","unstructured":"Chen Y, Yang Z, Liu Y, Li Y, Zhong Z, McDowell G, et al. Exploring the prognostic impact of triglyceride-glucose index in critically ill patients with first-ever stroke: insights from traditional methods and machine learning-based mortality prediction. Cardiovasc Diabetol. 2024;23(1):443. https:\/\/doi.org\/10.1186\/s12933-024-02538-y.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3014_CR47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12933-022-01541-5","volume":"21","author":"H Li","year":"2022","unstructured":"Li H, Zuo Y, Qian F, Chen S, Tian X, Wang P, et al. Triglyceride-glucose index variability and incident cardiovascular disease: a prospective cohort study. Cardiovasc Diabetol. 2022;21(1):105. https:\/\/doi.org\/10.1186\/s12933-022-01541-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3014_CR48","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1186\/s12877-022-03689-x","volume":"22","author":"X Ren","year":"2022","unstructured":"Ren X, Jiang M, Han L, Zheng X. Estimated glucose disposal rate and risk of cardiovascular disease: evidence from the China Health and Retirement Longitudinal Study. BMC Geriatr. 2022;22(1):968. https:\/\/doi.org\/10.1186\/s12877-022-03689-x.","journal-title":"BMC Geriatr"},{"issue":"1","key":"3014_CR49","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12933-021-01394-4","volume":"20","author":"A Zabala","year":"2021","unstructured":"Zabala A, Darsalia V, Lind M, Svensson AM, Franz\u00e9n S, Eliasson B, et al. Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort study. Cardiovasc Diabetol. 2021;20(1):202. https:\/\/doi.org\/10.1186\/s12933-021-01394-4.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3014_CR50","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12933-024-02256-5","volume":"23","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Zhao L, Lu Y, Xiao Y, Zhou X. Insulin resistance assessed by estimated glucose disposal rate and risk of incident cardiovascular diseases among individuals without diabetes: findings from a nationwide, population based, prospective cohort study. Cardiovasc Diabetol. 2024;23(1):194. https:\/\/doi.org\/10.1186\/s12933-024-02256-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3014_CR51","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13098-022-00915-9","volume":"14","author":"C Liu","year":"2022","unstructured":"Liu C, Liu X, Ma X, Cheng Y, Sun Y, Zhang D, et al. Predictive worth of estimated glucose disposal rate: evaluation in patients with non-ST-segment elevation acute coronary syndrome and non-diabetic patients after percutaneous coronary intervention. Diabetol Metab Syndr. 2022;14(1):145. https:\/\/doi.org\/10.1186\/s13098-022-00915-9.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"3014_CR52","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12933-023-01794-8","volume":"22","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, Fang Z, Zhang X, Wen Y, Lu J, He S, et al. Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study. Cardiovasc Diabetol. 2023;22(1):75. https:\/\/doi.org\/10.1186\/s12933-023-01794-8.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"3014_CR53","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/mol.0000000000000753","volume":"32","author":"G Reyes-Soffer","year":"2021","unstructured":"Reyes-Soffer G. The impact of race and ethnicity on lipoprotein(a) levels and cardiovascular risk. Curr Opin Lipidol. 2021;32(3):163\u20136. https:\/\/doi.org\/10.1097\/mol.0000000000000753.","journal-title":"Curr Opin Lipidol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-026-03014-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-03014-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-03014-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:02:35Z","timestamp":1791378155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12944-026-03014-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3014"],"URL":"https:\/\/doi.org\/10.1186\/s12944-026-03014-0","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"4 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All study procedures performed were following the principles of the Declaration of Helsinki. Each individual signed a written consent form prior to participation. Approval No. 24005 was granted by the Institutional Review Board and the Independent Ethical Committee of Third Xiangya Hospital for this study\u2019s protocol for physical examinations and consent form.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"207"}}